Nila Kartika Wati

EHA 2026: Promising New Avenues Emerge for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Treatment

• Medical Research and Clinical Trials

EHA 2026: Promising New Avenues Emerge for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Treatment

Nila Kartika Wati June 16, 2026

GENEVA, SWITZERLAND – [Date of Publication] – The European Hematology Association (EHA) 2026 Congress has become a...

Read More Read more about EHA 2026: Promising New Avenues Emerge for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Treatment

Beyond the Diagnosis: Navigating the Complexities of Breast Cancer Recurrence

• Survivorship and Post-Treatment

Beyond the Diagnosis: Navigating the Complexities of Breast Cancer Recurrence

Nila Kartika Wati June 16, 2026

By Agendia | December 18, 2025 The moment a patient hears the words, "You have breast cancer,"...

Read More Read more about Beyond the Diagnosis: Navigating the Complexities of Breast Cancer Recurrence

Global Health Alert: WHO Monitors Hantavirus Outbreak Aboard MV Hondius

• Breast Cancer Prevention and Lifestyle

Global Health Alert: WHO Monitors Hantavirus Outbreak Aboard MV Hondius

Nila Kartika Wati June 16, 2026

GENEVA – The World Health Organization (WHO) is currently spearheading a complex international response to a rare...

Read More Read more about Global Health Alert: WHO Monitors Hantavirus Outbreak Aboard MV Hondius

Navigating Hair Loss During Cancer Treatment: A Comprehensive Guide to Choosing Wigs and Finding Support

• Survivorship and Post-Treatment

Navigating Hair Loss During Cancer Treatment: A Comprehensive Guide to Choosing Wigs and Finding Support

Nila Kartika Wati June 16, 2026

For many individuals, a cancer diagnosis brings with it a cascade of life-altering challenges. Among the most...

Read More Read more about Navigating Hair Loss During Cancer Treatment: A Comprehensive Guide to Choosing Wigs and Finding Support

Protecting Innovation in a Borderless Pharma Economy: The New Frontier of Globalized IP Strategy

• Chemotherapy and Targeted Therapy

Protecting Innovation in a Borderless Pharma Economy: The New Frontier of Globalized IP Strategy

Nila Kartika Wati June 16, 2026

In the modern pharmaceutical landscape, the journey of a drug from a laboratory bench to a patient’s...

Read More Read more about Protecting Innovation in a Borderless Pharma Economy: The New Frontier of Globalized IP Strategy

Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Dominance

• Chemotherapy and Targeted Therapy

Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Dominance

Nila Kartika Wati June 15, 2026

By Jacob Bell | June 15, 2026 Eli Lilly’s strategic bet on the biotech startup Ajax Therapeutics...

Read More Read more about Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Dominance

Global Health at a Crossroads: The 79th World Health Assembly Convenes in Geneva

• Global Breast Cancer Awareness

Global Health at a Crossroads: The 79th World Health Assembly Convenes in Geneva

Nila Kartika Wati June 15, 2026

GENEVA, Switzerland – The global health community descended upon the Palais des Nations this week as the...

Read More Read more about Global Health at a Crossroads: The 79th World Health Assembly Convenes in Geneva

The Shrinking Safety Net: The Growing Instability of Medicare’s Stand-Alone Drug Coverage

• Breast Cancer Legislation and Policy

The Shrinking Safety Net: The Growing Instability of Medicare’s Stand-Alone Drug Coverage

Nila Kartika Wati June 14, 2026

For millions of older Americans and people with disabilities, the promise of Medicare is anchored in the...

Read More Read more about The Shrinking Safety Net: The Growing Instability of Medicare’s Stand-Alone Drug Coverage

Navigating the New Frontier: How GLP-1 Medications Influence Outcomes in Body Contouring Surgery

• Breast Cancer Surgery and Reconstruction

Navigating the New Frontier: How GLP-1 Medications Influence Outcomes in Body Contouring Surgery

Nila Kartika Wati June 14, 2026

As the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide and liraglutide—reaches an all-time high, the...

Read More Read more about Navigating the New Frontier: How GLP-1 Medications Influence Outcomes in Body Contouring Surgery

A New Blueprint for Care: Breast Cancer Canada Proposes National Transformation in Federal Pre-Budget Submission

• Psychosocial Support and Mental Health

A New Blueprint for Care: Breast Cancer Canada Proposes National Transformation in Federal Pre-Budget Submission

Nila Kartika Wati June 14, 2026

In a decisive move to overhaul the landscape of oncology in Canada, Breast Cancer Canada (BCC) has...

Read More Read more about A New Blueprint for Care: Breast Cancer Canada Proposes National Transformation in Federal Pre-Budget Submission